Aichi, Japan

Yukihiro Nishiyama


Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1991-1994

Loading Chart...
5 patents (USPTO):

Title: Innovations of Yukihiro Nishiyama

Introduction

Yukihiro Nishiyama is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. With a total of 5 patents to his name, his work has garnered attention for its potential therapeutic applications.

Latest Patents

One of his latest inventions is related to phenoxyphosphoryloxymethyl cyclobutyl purines. This invention focuses on cyclobutane derivatives that exhibit high oral absorbability and are metabolized in vivo into useful compounds. These compounds are expected to serve as effective antiviral agents. Another significant patent involves 2-halogeno-oxetanocin A and its phosphoric ester. This compound has demonstrated strong antiviral activity and is characterized by its resistance to inactivation by adenosine deaminase, making it a promising candidate for therapeutic drugs targeting viral diseases.

Career Highlights

Yukihiro Nishiyama is associated with Nippon Kayaku Kabushiki Kaisha, a company known for its innovative pharmaceutical solutions. His work has been instrumental in advancing the company's research and development efforts in antiviral therapies.

Collaborations

He has collaborated with notable colleagues such as Seiichi Saito and Nobuyoshi Shimada, contributing to the collective expertise in their research endeavors.

Conclusion

Yukihiro Nishiyama's contributions to the field of pharmaceuticals, particularly in antiviral agents, highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing medical science and addressing viral diseases effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…